Valvular heart disease and liver transplantation

Cardiovascular Diseases and Liver Transplantation

Volumn , Issue , 2011, Pages 67-81

  Gardner, Andrew I ^a   Gibbs, Neville M ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868150527     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (21)

1. Prasad MK, Rozario CJ, Arrowsmith JE. Anesthetic management of the patient with carcinoid heart disease. In: Arrowsmith JE, Simpson J. Problems in Anesthesia: Cardiothoracic Surgery. London: Martin Dunitz. 2002. pp 293-299.
2. Moller S, Dumcke CW, Krag A. The heart and the liver. Expert Rev. Gastroenterol Hepatol 2009; 3: 51-64.
3. Matyal R, Mahmood F. Assessment of valvular function and abnormalities with TEE. Int Anesthesiol Clin 2008; 46:63-81.
4. Perrino AC, Reeves ST. A practical approach to transesophageal echocardiography. 2nd ed. Philadelphia, Lippincott Williams and Wilkins, 2008.
5. Fisouli F, Salzberg SP, Rahmanian PB, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 2007; 13:990-995.
6. An Y, Xiao YB, and Zhong QJ. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes. Eur Surg Res 2007; 39:67-74.
7. Pollard RJ, Sid A, Gibby GL. Aortic stenosis with end-stage liver disease: prioritizing surgical and anesthetic therapies. J Clin Anesth 1998 10:253-261.
8. Sun JCJ, Davidson MJ, Lamy A, Eikelboom JW. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 2009; (374):565-576.
9. Stangier J, Stahle H, Rathgen, Roth W, Shaker-Nejad K. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not effected by moderate hepatic impairment. J Clin Pharmacol 2008; 48:1411-1419.
10. Watts SA, Gibbs NM Outpatient management of the chronically anticoagulated patient for elective surgery. Anaesth Intensive Care 2003; 31:145-154.
11. Shlebak A, Malik I. Managing heparin anticoagulation in patients with prosthetic cardiac valves: balancing the risk. Heart 2009; 95:1643-1645.
12. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Eng J Med 1996; 335; 407-416.
13. Paterson DL, Dominquez EA, Chang FY, Snydman DR, Singh N. Infective endocarditis in solid organ transplant recipients. Clin Infect Dis 1998; 26:689-694.
14. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Eng J Med 2001; 345; 1318-1330.
15. O'Gara P, Braunwald E. Valvular Heart Disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL et al, eds. Harrison's principles 17th ed, New York, McGraw-Hill, 2008.
16. Zigelman CZ. Edelstein PM. Aortic valve stenosis. Anesthesiol. Clin 2009; 27: 519-532.
17. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second and third generation self-expanding core valve prosthesis: device success and 30-day clinical outcome. J Am Col Cardiol 2007; 50: 69-76.
18. Sukernik MR, Martin DM. Anesthetic management for the surgical treatment of valvular heart disease. In Hensley R, Martin D, Gravlee GP, eds. A practical approach to cardiac anesthesia. 4th Ed, New York, Lippincott Williams and Wilkins. 2008, pp 198-229.
19. Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet 2009; 375: 1271-1283.
20. Otto CM, Salerno CT. Timing of surgery in symptomatic mitral regurgitation. N Eng J Med 2005; 352: 928-929.
21. Fabbroni D, Bellamy M. Anaesthesia for hepatic transplantation. Continuing Education in Anaesthesia, Critical Care and Pain 2006; 6: 171-175.